Industry players have for long relied upon scientific findings to diffuse debatable claims for health supplements. They find this a key part of galvanizing support for popular health supplements. The case in point here is omega-3 supplements. People use omega-3 pills to ward off heart disease risks. And, they also hold potential in increasing the survival rates of patients. However, the only thorny issue here is the risk of prostate cancer. Health experts have associated the risk to high levels of omega-3, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Researchers at Intermountain Healthcare Heart Institute recently chose to investigate this in two of their studies.
High Omega-3 Levels Beneficial for Patients with Heart Diseases
They presented their research in American Heart Association’s Scientific Sessions. The research involved 87 patients in the INSPIRE Registry of the institute. These had prostate cancer. The researchers compared the results with their control group and found that they there was no association between higher levels of omega-3 with prostate cancer. They looked at the plasma levels of two common ones—EPA and DHA.
In another study, the research looked at people with no prior history of heart diseases. They underwent coronary angiography. Surprisingly, the diagnostic showed that 40% had high risk that may also lead to death. The researchers also measured plasma levels of key metabolites of omega-3. On following up in consequent years, the study found that patients with high metabolites of omega-3 suffered lower risk. Eventually, they could see a doctor and get the heart disease diagnosed. To say this in another way—omega-3 levels had boosted the survival rates in people, regardless of the fact that they tested favorably on angiography or not.